Neurostimulation Devices Market 2017-2027

LONDON, August 30, 2017 /PRNewswire/ --

Forecasts by Product (Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators and Others), by Application (Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson's Disease and Others) and Geography 

Neurostimulation - our new study reveals trends, R&D progress, and predicted revenues
Where is the Neurostimulation market heading? If you are involved in this sector you must read this brand new report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

Discover how to stay ahead
Our 178-page report provides 102 tables, charts, and graphs, providing over 2900 unique datapoints. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Neurostimulation market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are forecasts for 6 Neurostimulation Products and 7 Neurostimulation Applications, each forecasted at a global, regional and national level.

Neurostimulation Software, by Product
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Cortical Stimulators
• Others

Neurostimulation, by Application
• Pain Management
• Epilepsy
• Urinary and Fecal Incontinence
• Hearing Loss
• Gastroparesis
• Parkinson's Disease
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 6 regional and 10 leading national markets:
• North America:
• The US
• Canada

• Europe:
• Germany
• The UK
• Italy
• Spain
• France
• Rest of Europe

• APAC:
• Japan
• China
• India
• Rest of Asia-Pacific

• RoW:
• Latin America
• Middle East and Africa
• Other Countries

The report also includes profiles and for some of the leading companies in the Neurostimulation market, with a focus on the Neurostimulation segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the US in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth
Overall world revenue for Neurostimulation will surpass $19bn in 2027, our work calculates. We predict strong revenue growth through to 2027. With increasing incidence of neurological diseases, the demand for neurostimulation devices is expected to increase significantly in the next few years.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Neurostimulation Market report helps you
In summary, our 178-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for the Neurostimulation market and 2 different segmentations, with forecasts for 6 Products and 7 Applications at a Global, Regional and National level - discover the industry's prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 6 regional and 10 key national markets - North America, Europe, Asia-Pacific, Latin America, Middle East and Africa are forecasted, as well as the US, Canada, Germany, France, the UK, Italy, Spain, Japan, China, India,
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market - including company profiles for 10 companies involved in the Neurostimulation market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Neurostimulation market and leading companies. You will find data, trends and predictions.

Get our report today Neurostimulation Devices Market 2017-2027: Forecasts by Product (Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators and Others), by Application (Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson's Disease and Others) and Geography. Avoid missing out - get our report now.

To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100

Or click on https://www.visiongain.com/

480 Biomedical Inc.

Abbott Laboratories

Accellent

Advanced Bionics, LLC

Advanced Neuromodulation Systems

Allergan Plc

Anterios, Inc.

Argon Medical Devices  Inc.

B. Braun

Baxter International, Inc.

Bayer AG

BioControl Medical (B.C.M) Ltd.

BIOMED CENTRAL LTD

Bionx Medical Technologies  Inc.

Boston Scientific Corporation

Canadian Institutes of Health Research

Carestream Health, Inc.

Cochlear Ltd.

Codman & Shurtleff, Inc.

Cogentix Medical

Cyberonics  Inc.

Deep Brain Innovations

Edwards Lifesciences Corp.

EndoStim Inc.

EnteroMedics Inc

GE HEALTHCARE LTD

Globus Medical, Inc.

Helius Medical Technologies, Inc.

Hitachi Health Care Manufacturing  K.K.

Hologic, Inc.

Inspire Medical Systems Inc.

IntraPace, Inc.

Johnson & Johnson

Johnson & Johnson Medical Limited

LifeTech Scientific Corp.

LivaNova PLC

Mainstay Medical International Plc

MED-EL

Medtronic Plc

Medtronic Usa  Inc.

Mindray Medical International Ltd.

Natus Medical, Inc.

NDI Medical LLC

Neurologica Corp.

NeuroMetrix, Inc.

Neuronetics, Inc.

NeuroPace, Inc.

NeuroSigma, Inc.

Nevro Corp

Nexstim Oyj

Penumbra, Inc.

Pfizer Inc.

Quest Diagnostics

Roche Holding AG

Royal Philips NV

Siemens AG

Smith & Nephew Plc

Soterix Medical Inc

St. Jude Medical

Stryker Corp.

Synapse Biomedical Inc.

Terumo Corp.

Tesla, Inc.

Toshiba Medical Systems Corporation

XOGRAPH HEALTHCARE LTD

Zimmer Biomet Holdings, Inc.

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com